AzTrials
AzTrials

Lifestyle-related ConditionPREVFUNKTIONNCT06309342

Prevention of Lifestyle-related Disorders Based on Functional Examinations

A study testing PREVFUNKTION in people with Lifestyle-related Condition, run by Lena Bornhoft at 2 sites in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this randomised controlled trial is to examine the effects of functional examinations and feedback/support on healthy 40-year-olds. The main questions it aims to answer are: • Does feedback and motivational interviewing after testing physical function motivate inactive middle-aged people to increase their… Read more about this study

Who is it for?
Ages 39 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Lifestyle-related Condition
What is being tested?
PREVFUNKTION
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
2 sitesSweden
Study dates
28 Aug 2024to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 39 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 40 years of age
  • Relatively normal general mobility - can walk without support and have no self-reported difficulties with using all four extremities - in order to be able to perform standardised functional performance tests.
  • Self-assessed as physically inactive (level 1 or 2 on the Saltin Grimby Physical Activity Level Scale) as inactive people stand to gain most from this intervention.

Who cannot join

  • Verbally self-reported physical activity at level three or four on Saltin Grimby Physical Activity Level Scale.
  • Severe mental illness or intellectual impairment, as participants will be expected to fill out questionnaires and should have the ability to follow healthcare advice independently should they choose to do so.
  • Pregnancy and/or on-going treatment requiring hospital-based services, to increase probability of baseline values which reflect usual capacity.
  • No language restrictions are planned but participants needing interpreter help should arrange this themselves.

Trial locations and contacts

2 sites in 1 country.

Sweden2 sites
  • Capio Vårdcentral/Rehab Kvillebäcken

    Gothenburg

  • Familjeläkarna i Mölnlycke

    Mölnlycke, Region Västra Götaland, 43544

Other trials in Sweden

About this study

Official title: Prevention of Lifestyle-related Disorders With Early Examinations of Health and Function and Individualised Functional Profiles - a Randomised Controlled Trial

The goal of this randomised controlled trial is to examine the effects of functional examinations and feedback/support on healthy 40-year-olds. The main questions it aims to answer are: • Does feedback and motivational interviewing after testing physical function motivate inactive middle-aged people to increase their physical activity level? • Does the intervention lead to health benefits over time - less pain, better function, higher health-related quality of life, fewer risk factors for lifestyle-related illness? Participants will: • undergo medical and functional health examinations, • their physical activity level will be measured, • receive feedback and advice based on both parts of the examinations, • receive a functional profile, • be supported in goalsetting for lifestyle changes. Researchers will compare with a control group who, after the examinations, receive feedback only from the medical examination to see if participants become more physically active, achieve better function, become more motivated to make lifestyle changes, reduce risk factors for lifestyle-related illness, achieve health benefits and better health-related quality of life.

Read the detailed description

Relatively healthy 40-year-olds will be examined at baseline and 1 year with both standard medical and newly developed functional examinations and physical activity level will be measured with accelerometers. The intervention group will receive feedback on all their results. A functional profile will be compiled and explained to each participant and they will receive support in setting relevant goals for lifestyle changes and making realistic plans to achieve them. The control group will also be examined as above but will receive feedback and advice based only on the standard medical examination.

Being tested
PREVFUNKTION, Control
Keywords
Lifestyle, Prevention, Physical activity, Fitness, Health examination
Medical subject headings
Mental Disorders, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PREVFUNKTIONOther

    Functional profile and advice concerning cardiovascular fitness level, strength, mobility, balance and posture. Motivational interview and support in goalsetting to make lifestyle changes.

  • ControlOther

    Physical activity measured with accelerometers. Functional examination. Medical examination and advice concerning weight measures, blood pressure and standard blood tests.

Study groups in NCT06309342
Study groupRoleWhat they receive
PREVFUNKTIONExperimentalMedical examination. Functional examination. Measurement of physical activity. Questionnaires on health, function and lifestyle. Feedback and advice based on medical examination. Feedback and advice based on functional examination. Functional profile. Support in setting goals for lifestyle changes.
Receives: Other: PREVFUNKTION; Other: Control
ControlActive comparatorMedical examination. Functional examination. Measurement of physical activity. Questionnaires on health, function and lifestyle. Feedback and advice based on medical examination.
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in objectively measured physical activity

    Mean daily minutes in moderate-to-very vigorous physical activity measured with accelerometers for 1 week

    Measured: Change between baseline and 1-year follow-up

  2. Change in objectively measured sedentary behaviour

    Mean daily minutes of sedentary behaviour measured with accelerometers for 1 week

    Measured: Change between baseline and 1-year follow-up

Secondary outcomes (56)
  1. Change in cardiovascular fitness

    Fitness level measured in ml/kg/min using the Ekblom Bak submaximal ergometer test

    Measured: Change between baseline and 1-year follow-up

  2. Change in motivation level

    Motivation to make lifestyle changes to improve health on an 11-point numerical rating scale.

    Measured: Change between baseline and 1-year follow-up

  3. Proportion achieved goals

    Proportion of goals achieved of the goals set by the intervention group at baseline

    Measured: Measured only at 1-year follow-up

  4. Change in fitness level

    Point level on the study-specific functional profile arm for fitness where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better fitness level.

    Measured: Change between baseline and 1-year follow-up

  5. Change in strength upper extremity

    Point level on the study-specific functional profile arm for strength upper extremity where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Measured: Change between baseline and 1-year follow-up

  6. Change in strength lower extremity

    Point level on the study-specific functional profile arm for strength lower extremity where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Measured: Change between baseline and 1-year follow-up

  7. Change in strength trunk muscles

    Point level on the study-specific functional profile arm for strength trunk where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better strength.

    Measured: Change between baseline and 1-year follow-up

  8. Change in balance

    Point level on the study-specific functional profile arm for balance where points are given for grade of deviation from norm. Minimum -2, maximum +2. Higher scores indicate better balance.

    Measured: Change between baseline and 1-year follow-up

  9. Change in mobility

    Point level on the study-specific functional profile arm for mobility where points are given for grade of deviation from norm. Minimum -2, maximum 0. Lower score indicates mobility dysfunction, 0 indicates normal mobility.

    Measured: Change between baseline and 1-year follow-up

  10. Change in posture

    Point level on the study-specific functional profile arm for posture where points are given for grade of deviation from norm. Minimum -1, maximum 0. Lower score indicates postural deviations, 0 indicates normal postural measurements.

    Measured: Change between baseline and 1-year follow-up

  11. Change in weight measures

    Point level on the study-specific functional profile arm for weight where points are given for grade of deviation from recommended values. Minimum -2, maximum 0. Lower score indicates overweight (or underweight), 0 indicates normal weight.

    Measured: Change between baseline and 1-year follow-up

  12. Change in pain

    Point level on the study-specific functional profile arm for pain where points are given for number of pain locations, score on the Örebro Musculoskeletal Pain Screening Questionnaire and on the pain question on Euroqol-5 dimensions-3 levels. Minimum -2, maximum 0. Lower score indicates more pain, 0 indicates no pain.

    Measured: Change between baseline and 1-year follow-up

  13. Change in physical activity

    Point level on the study-specific functional profile arm for physical activity where points are given for grade of deviation from recommended values when objectively measured with accelerometers. Minimum -2, maximum +2. Increased point value indicates higher physical activity level.

    Measured: Change between baseline and 1-year follow-up

  14. Change in handgrip strength

    Measured with Jamar handdynamometer (kg)

    Measured: Change between baseline and 1-year follow-up

  15. Change in biceps strength

    Measured with 30-second biceps test (number repetitions)

    Measured: Change between baseline and 1-year follow-up

  16. Change in leg strength

    Measured with 30-second chair-stand test (number repetitions)

    Measured: Change between baseline and 1-year follow-up

  17. Change in calf strength

    Measured with single-foot heel rises (number repetitions)

    Measured: Change between baseline and 1-year follow-up

  18. Change in ventral trunk strength

    Measured with plank test (seconds)

    Measured: Change between baseline and 1-year follow-up

  19. Change in dorsal trunk strength

    Measured with back endurance test (seconds)

    Measured: Change between baseline and 1-year follow-up

  20. Change in lower trunk strength

    Measured with supine bridge test (seconds)

    Measured: Change between baseline and 1-year follow-up

  21. Change in static balance - 1

    Measured with stand-on-one-leg-eyes-open test (seconds)

    Measured: Change between baseline and 1-year follow-up

  22. Change in static balance - 2

    Measured with stand-on-one-leg-eyes-closed test (seconds)

    Measured: Change between baseline and 1-year follow-up

  23. Change in static balance - 3

    Measured with sharpened Romberg test (seconds)

    Measured: Change between baseline and 1-year follow-up

  24. Change in dynamic balance

    Measured with functional reach test (centimeters)

    Measured: Change between baseline and 1-year follow-up

  25. Change in mobility - 1

    Measured with sit-rise test (points)

    Measured: Change between baseline and 1-year follow-up

  26. Change in mobility - 2

    Measured with finger-floor test (centimeters)

    Measured: Change between baseline and 1-year follow-up

  27. Change in mobility - 3

    Measured with lateral flexion test (centimeters)

    Measured: Change between baseline and 1-year follow-up

  28. Change in hypermobility score

    Measured with Beighton hypermobility score with point values between 0 and 9 where score over 4 indicate general hypermobility.

    Measured: Change between baseline and 1-year follow-up

  29. Change in neck mobility

    Measured with occiput-to-wall test (points)

    Measured: Change between baseline and 1-year follow-up

  30. Change in foot pronation

    Measured with navicular drop test (millimeters)

    Measured: Change between baseline and 1-year follow-up

  31. Change in habitual stance

    Measured with patella mobility test (points)

    Measured: Change between baseline and 1-year follow-up

  32. Change in health-related quality of life assessed with EQ5D index

    Measured with index values for Euroqol-5 dimensions-3 levels. Minimum -0.59, maximum +1. Higher scores indicate better health-related quality of life.

    Measured: Change between baseline and 1-year follow-up

  33. Change in health-related quality of life assessed with EQ5D VAS

    Measured with the 100-point barometer for Euroqol-5 dimensions-3 levels. Minimum 0, maximum 100. Higher scores indicate better health-related quality of life.

    Measured: Change between baseline and 1-year follow-up

  34. Change in self-reported physical activity assessed with Swedish questionnaire

    Measured with Swedish National Board of Health and Welfare questionnaire with 2 questions on physical activity and exercise measured in minutes. Minimum 0, maximum measured value 540. Increasing values indicate higher levels of physical activity.

    Measured: Change between baseline and 1-year follow-up

  35. Change in self-reported physical activity assessed with Saltin Grimby Physical Activity Level Scale (SGPALS)

    Measured with SGPALS with point values between 1 and 4 where increasing values indicate higher level of physical activity.

    Measured: Change between baseline and 1-year follow-up

  36. Change in self-reported sedentary time

    Measured in hours per day with SED-GIH questionnaire with values between 0 and 24 where increasing sedentary time is considered to have a negative impact on health.

    Measured: Change between baseline and 1-year follow-up

  37. Change in risk for chronic pain and sickness absence assessed with Örebro Musculoskeletal Pain Screening Questionnaire

    Measured with Örebro Musculoskeletal Pain Screening Questionnaire with scores between 1 and 100 where increasing values indicate higher risk for chronic pain and sickness absence.

    Measured: Change between baseline and 1-year follow-up

  38. Change in number of pain locations

    Measured with a pain diagram

    Measured: Change between baseline and 1-year follow-up

  39. Change in proportion smokers

    Proportion smokers in each group

    Measured: Change between baseline and 1-year follow-up

  40. Change in proportion acceptable level blood glucose

    Proportion with blood glucose levels within recommended limits (4.0-6.0 mmol/L)

    Measured: Change between baseline and 1-year follow-up

  41. Change in proportion acceptable level serum cholesterol

    Proportion with cholesterol levels within recommended limits (3.3-6.9 mmol/L)

    Measured: Change between baseline and 1-year follow-up

  42. Change in proportion acceptable level triglycerides

    Proportion with triglyceride levels within recommended limits (0,45-2.6)

    Measured: Change between baseline and 1-year follow-up

  43. Change in proportion acceptable blood pressure

    Proportion of participants with blood pressure within recommended limits

    Measured: Change between baseline and 1-year follow-up

  44. Change in proportion normal body mass index (BMI)

    Proportion of participants with BMI within recommended limits

    Measured: Change between baseline and 1-year follow-up

  45. Change in proportion acceptable waist circumference

    Proportion of participants with waist circumference below recommended level

    Measured: Change between baseline and 1-year follow-up

  46. Change in stress symptoms assessed with Stress and Crisis Inventory-93

    Measured with Stress and Crisis Inventory-93 questionnaire. Minimum 0, maximum 140, with higher values indicating higher stress levels.

    Measured: Change between baseline and 1-year follow-up

  47. Change in depression and anxiety symptoms assessed with Hospital Anxiety and Depression Scale

    Measured with Hospital Anxiety and Depression Scale. Minimum 0, maximum 42 with 21 as maximum for anxiety and 21 maximum for depression. Increasing values indicate more severe symptoms.

    Measured: Change between baseline and 1-year follow-up

  48. Correlation between self-assessed and objectively measured fitness

    Correlation between fitness self-assessed on a 5-point Likert scale and point value on the fitness arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  49. Correlation between self-assessed and objectively measured fitness - 2

    Correlation between fitness self-assessed on a 5-point Likert scale and fitness grade on the Ekblom Bak fitness test (5 point Likert scale). Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  50. Correlation between self-assessed and objectively measured strength upper extremity

    Correlation between upper extremity strength self-assessed on a 5-point Likert scale and point value for the strength upper extremity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  51. Correlation between self-assessed and objectively measured strength lower extremity

    Correlation between lower extremity strength self-assessed on a 5-point Likert scale and point value for the strength lower extremity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  52. Correlation between self-assessed and objectively measured balance

    Correlation between balance self-assessed on a 5-point Likert scale and point value on the balance arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  53. Correlation between self-assessed and objectively measured physical activity

    Correlation between self-assessed walking ability on a 5-point Likert scale and point value on the physical activity arm on the study-specific functional profile. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  54. Correlation between self-assessed and objectively measured physical activity - 2

    Correlation between self-assessed walking ability on a 5-point Likert scale and number of daily minutes in moderate-to-very vigorous physical activity measured with accelerometers. Minimum -1, maximum +1. Higher values indicate better correlation between the 2 measures.

    Measured: Change between baseline and 1-year follow-up

  55. Change in relative physical activity

    Mean daily minutes of moderate-to-very vigorous physical activity measured with accelerometers for 1 week where moderate is individually calculated in relation to fitness level (46% of VO2max).

    Measured: Change between baseline and 1-year follow-up

  56. Change in sufficient physical activity

    Number of mean daily minutes of physical activity measured with accelerometers for 1 week above a known health-promoting level based on a fitness level of 31.5 ml/kg for women and 35 ml/kg for men.

    Measured: Change between baseline and 1-year follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2024
  2. Study start28 Aug 2024
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Initial examinations and data collection are made before randomisation. Randomisation then leads to the two groups of participants receiving different amounts of feedback and support. Follow-up examinations and data collection are made after one year in both groups.
Masking
Single blind
Who is masked
Investigator
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06309342
Sponsor's protocol ID
VGRFOU-278257
Acronym
PREVFUNKTION
Status last verified
Sep 2026
First submitted
29 Feb 2024
Last updated
9 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing PREVFUNKTION in people with Lifestyle-related Condition, run by Lena Bornhoft at 2 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in objectively measured physical activity (time frame: Change between baseline and 1-year follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in